Kelvin Brockbank

Chief Technology Officer - Preservation Technologies, LifeNet Health

Charleston, South Carolina, United States

About

MAJOR GOALS: Development of products and services that help increase the quality of cells, tissues and organs. SELECTED ACCOMPLISHMENTS AND RESULTS: •Achieved international recognition in the fields of tissue transplantation and cardiovascular devices. Over 450 publications, patents, and presentations at major conventions. More than $10,000,000 in competitive grants. •Creative force in product marketing. Developed technical literature, worked with sales and marketing at medical conventions, liaised with clinicians in several disciplines and lectured at Surgery Grand Rounds and Seminars. •Developed and patented new technologies that have benefited thousands of patients and established two publicly listed companies. Specialties: Preservation of living materials. Product research and development, consulting and small business grant writing for Life Science companies. Personal emphasis on product development and low temperature biology related to cardiovascular, stem cell, diabetes, liver disease and orthopedic tissue applications.

Experience

  • Chief Technology Officer - Preservation Technologies at LifeNet Health
    Jan 2026 - Present · 6 mos

  • Adjunct Professor, Comparative Medicine at Medical University of South Carolina
    Jun 2024 - Present · 2 yrs 1 mo

  • Research Professor of Bioengineering at Clemson University
    Oct 2014 - Present · 11 yrs 9 mos

  • President at KGB Associates, Inc.
    Jan 1995 - Present · 31 yrs 6 mos

    KGB Associates, Inc., provides product research and development consulting and grant writing services to Life Science companies and academic organizations.

  • Chief Executive Officer at Tissue Testing Technologies LLC
    Dec 2014 - Apr 2025 · 10 yrs 5 mos

    Effective May 31st, 2025 I acquired the stock of my minority partner, Lifeline Scientific, Inc., in Tissue Testing Technologies LLC. I own 100% of the T3LLC stock. LifeNet Health acquired Tissue Testing Technologies LLC from me in mid December 2025. My key personnel and I joined LifeNet Health as employees on January 1st, 2026.